Avant Diagnostics Inc. Receives FDA IRB Approval for OvaDx(R) Ovarian Cancer Validation Test Specimens SCOTTSDALE, Ariz., Oct. 07, 2015 (GLOBE NEWSWIRE) -- Avant Diagnostics, Inc. (OTCQB:AVDX) (“Avant”), an innovative in vitro diagnostics company, was notified by DOCRO, its independent clinical...